Nutrition and diet in the era of genomics

Genomic and Personalized Medicine, Two-Vol Set

Volumn , Issue , 2009, Pages 1204-1220

  Ordovas, Jose M ^a   Corella, Dolores ^b,c  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861836894     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369420-1.00098-6     Document Type: Chapter

References (186)

1. Abidov M.T., del Rio M.J., Ramazanov T.Z., Klimenov A.L., Dzhamirze S., Kalyuzhin O.V. Effects of Aralia mandshurica and Engelhardtia chrysolepis extracts on some parameters of lipid metabolism in women with nondiabetic obesity. Bull Exp Biol Med 2006, 141:343-346.
2. Afman L., Muller M. Nutrigenomics: From molecular nutrition to prevention of disease. J Am Diet Assoc 2006, 106:569-576.
3. Armstrong B., Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975, 15:617-631.
4. Auricchio S., Greco L., Troncone R. What is the true prevalence of coeliac disease?. Gastroenterol Int 1990, 3:140-142.
5. Bailey L.B. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C>T polymorphism affect cancer risk: Intake recommendations. J Nutr 2003, 133:3748-3753.
6. Barrett J.C., Cardon L.R. Evaluating coverage of genome-wide association studies. Nat Genet 2006, 38:659-662.
7. Bell C.G., Walley A.J., Froguel P. The genetics of human obesity. Nat Rev Genet 2005, 6:221-234.
8. Benahmed M., Mention J.J., Matysiak-Budnik T., Cerf-Bensussan N. Celiac disease: A future without gluten-free diet?. Gastroenterology 2003, 125:1264-1267.
9. Bickel H., Gerrard J., Hickmans E.M. Influence of phenylalanine intake on phenylketonuria. Lancet 1953, 2:812-813.
10. Bingham S.A. Biomarkers in nutritional epidemiology. Public Health Nutr 2002, 5:821-827.
11. Bodlaj G., Stocher M., Hufnagl P., Hubmann R., Biesenbach G., Stekel H., Berg J. Genotyping of the lactase-phlorizin hydrolase -13910 polymorphism by LightCycler PCR and implications for the diagnosis of lactose intolerance. Clin Chem 2006, 52:148-151.
12. Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol 2006, 7:149-156.
13. Bos G., Dekker J.M., Feskens E.J., Ocke M.C., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., Jansen H. Interactions of dietary fat intake and the hepatic lipase ?480C?T polymorphism in determining hepatic lipase activity: The Hoorn Study. Am J Clin Nutr 2005, 81:911-915.
14. Brotman D.J., Girod J.P. The metabolic syndrome: A tug-of-war with no winner. Cleve Clin J Med 2002, 69:990-994.
15. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003, 348:1625-1638.
16. Campbell A.K., Waud J.P., Matthews S.B. The molecular basis of lactose intolerance. Sci Prog 2005, 88:157-202.
17. Cederbaum S. Phenylketonuria: An update. Curr Opin Pediatr 2002, 14:702-706.
18. Chen J., Giovannucci E., Kelsey K., Rimm E.B., Stampfer M.J., Colditz G.A., Spiegelman D., Willett W.C., Hunter D.J. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996, 56:4862-4864.
19. Chen J., Stampfer M.J., Hough H.L., Garcia-Closas M., Willett W.C., Hennekens C.H., Kelsey K.T., Hunter D.J. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998, 58:3307-3311.
20. Collins, F.S., Green, E.D., Guttmacher, A.E., Guyer, M.S., US National Human Genome Research Institute (2003). A vision for the future of genomics research. Nature 422, 835-847.
21. Corella D., Ordovas J.M. Single nucleotide polymorphisms that influence lipid metabolism: Interaction with dietary factors. Annu Rev Nutr 2005, 25:341-390.
22. Corella D., Ordovas J.M. Integration of environment and disease into "omics" analysis. Curr Opin Mol Ther 2005, 7:569-576.
23. Corella D., Tucker K., Lahoz C., Coltell O., Cupples L.A., Wilson P.W., Schaefer E.J., Ordovas J.M. Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: The Framingham Offspring Study. Am J Clin Nutr 2001, 73:736-745.
24. Corella D., Qi L., Sorli J.V., Godoy D., Portoles O., Coltell O., Greenberg A.S., Ordovas J.M. Obese subjects carrying the 11482G>A polymorphism at the perilipin locus are resistant to weight loss after dietary energy restriction. J Clin Endocrinol Metabol 2005, 90:5121-5126.
25. Corella D., Qi L., Tai E.S., Deurenberg-Yap M., Tan C.E., Chew S.K., Ordovas J.M. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes Care 2006, 29:1313-1319.
26. Corthesy-Theulaz I., den Dunnen J.T., Ferre P., Geurts J.M., Muller M., van Belzen N., van Ommen B. Nutrigenomics: The impact of biomics technology on nutrition research. Ann Nutr Metab 2005, 49:355-365.
27. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., Lander E.S. High-resolution haplotype structure in the human genome. Nat Genet 2001, 29:229-232.
28. Daniel H. Genomics and proteomics: Importance for the future of nutrition research. Br J Nutr 2002, 87(Suppl. 2):305-311.
29. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8:1-21.
30. DeBusk R.M., Fogarty C.P., Ordovas J.M., Kornman K.S. Nutritional genomics in practice: Where do we begin?. J Am Diet Assoc 2005, 105:589-598.
31. Dejar D., Pereira S.P., Ciclitira P.J. The pathogenesis of coeliac disease. Int J Biochem Cell Biol 2004, 36:17-24.
32. Doll R., Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981, 66:1191-1308.
33. Emmerson B.T. The management of gout. N Engl J Med 1996, 334:445-451.
34. Enattah N.S., Sahi T., Savilahti E., Terwilliger J.D., Peltonen L., Jarvela I. Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002, 30:233-237.
35. Evans D.M., Cardon L.R. Genome-wide association: A promising start to a long race. Trends Genet 2006, 22:350-354.
36. Ferguson A. Celiac disease, an eminently treatable condition, may be underdiagnosed in the United States. Am J Gastroenterol 1997, 92:1252-1254.
37. Fodinger M., Wagner O.F., Horl W.H., Sunder-Plassmann G. Recent insights into the molecular genetics of the homocysteine metabolism. Kidney Int Suppl 2001, 78:S238-sS242.
38. Fraser G.E. A search for truth in dietary epidemiology. Am J Clin Nutr 2003, 78:521S-525S.
39. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
40. Fuchs C.S., Giovannucci E.L., Colditz G.A., Hunter D.J., Stampfer M.J., Rosner B., Speizer F.E., Willett W.C. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999, 340:169-176.
41. Ghadirian P., Lacroix A., Maisonneuve P., Perret C., Potvin C., Gravel D., Bernard D., Boyle P. Nutritional factors and colon carcinoma: A case-control study involving French Canadians in Montreal, Quebec, Canada. Cancer 1997, 80:858-864.
42. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: A review. J Nutr 2002, 132:2350-2355.
43. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., Ascherio A., Willett W.C. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 1994, 54:2390-2397.
44. Go V.L., Butrum R.R., Wong D.A. Diet, nutrition, and cancer prevention: The postgenomic era. J Nutr 2003, 11:3830S-3836S.
45. Gomez P., Perez-Jimenez F., Marin C., Moreno J.A., Gomez M.J., Bellido C., Perez-Martinez P., Fuentes F., Paniagua J.A., Lopez-Miranda J. The H11002514 C/T polymorphism in the hepatic lipase gene promoter is associated with insulin sensitivity in a healthy young population. J Mol Endocrinol 2005, 34:331-338.
46. Gonzalez C.A. Nutrition and cancer: The current epidemiological evidence. Br J Nutr 2006, 96(Suppl 1):S42-S45.
47. Gonzalez C.A. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2006, 9(1A):124-126.
48. Guthrie R., Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963, 32:338-343.
49. Guyatt G.H., Haynes R.B., Jaeschke R.Z., Cook D.J., Green L., Naylor C.D., Wilson M.C., Richardson W.S. Users' guides to the medical literature: XXV. Evidence-based medicine: principles for applying the users' guides to patient care. Evidence-based medicine working group. JAMA 2000, 284:1290-1296.
50. Haga S.B., Khoury M.J., Burke W. Genomic profiling to promote a healthy lifestyle: Not ready for prime time. Nat Genet 2003, 34:347-350.
51. Hein D.W. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Letter 2000, Mar 15:112-113. 349-356.
52. Herbert A., Gerry N.P., McQueen M.B., Heid I.M., Pfeufer A., Illig T., Wichmann H.E., Meitinger T., Hunter D., Hu F.B., et al. A common genetic variant is associated with adult and childhood obesity. Science 2006, 312:279-283.
53. Hoffmann I. Transcending reductionism in nutrition research. Am J Clin Nutr 2003, 78:514-516.
54. Hollox E.J., Poulter M., Zvarik M., Ferak V., Krause A., Jenkins T., Saha N., Kozlov A.I., Swallow D.M. Lactase haplotype diversity in the Old World. Am J Hum Genet 2001, 68:160-172.
55. Holtzman N.A. Genetic variation in nutritional requirements and susceptibility to disease: Policy implications. Am J Clin Nutr 1988, 48:1510-1516.
56. Huang Y.S., Chern H.D., Wu J.C., Chao Y., Huang Y.H., Chang F.Y., Lee S.D. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol 2003, 98:1417-1422.
57. Jacobs D.R., Steffen L.M. Nutrients, foods, and dietary patterns as exposures in research: A framework for food synergy. Am J Clin Nutr 2003, 78:508S-513S.
58. Jang Y., Kim O.Y., Lee J.H., Koh S.J., Chae J.S., Kim J.Y., Park S., Cho H., Lee J.E., Ordovas J.M. Genetic variation at the perilipin locus is associated with changes in serum free fatty acids and abdominal fat following mild weight loss. Int J Obes 2006, 30:1601-1608.
59. Jansen H., Verhoeven A.J., Weeks L. Common C-to-T substitution at position H11002480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997, 17:2837-2842.
60. Jeenah M., Kessling A., Miller N., Humphries S.E. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 1990, 7:233-241.
61. Johnston S.D., Watson R.G.P., McMillan S.A., Sloan J., Love A.H.G. Coeliac disease detected by screening is not silent - simply unrecognized. Quart J Med 1998, 91:853-860.
62. Juo S.H., Wyszynski D.F., Beaty T.H., Huang H.Y., Bailey-Wilson J.E. Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-1 gene and apolipoprotein A-1 levels: a meta-analysis. Am J Med Genet 1999, 82:235-241.
63. Kang E.S., Cha B.S., Kim H.J., Kim S.H., Hur K.Y., Lee H.J., Shim W.S., Ahn C.W., Lee H.C. The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes. Diabetes Care 2006, 29:1320-1324.
64. Kang S.S., Wong P.W.K., Zhou J., Sora J., Lessick M., Ruggie N., Grcevich G. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 1988, 37:611-613.
65. Kaput J., Ordovas J.M., Ferguson L., van Ommen B., Rodriguez R.L., Allen L., Ames B.N., Dawson K., German B., Krauss R., et al. The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr 2005, 94:623-632.
66. Keusch G.T. What do -omics mean for the science and policy of the nutritional sciences?. Am J Clin Nutr 2006, 83:520S-522S.
67. Kidgell C., Winzeler E.A. Elucidating genetic diversity with oligonucleotide arrays. Chromosome Res 2005, 13:225-235.
68. Kipnis V., Midthune D., Freedman L., Bingham S., Day N.E., Riboli E., Ferrari P., Carroll R.J. Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutr 2002, 6A:915-923.
69. Kipnis V., Subar A.F., Midthune D., Freedman L.S., Ballard-Barbash R., Troiano R.P., Bingham S., Schoeller D.A., Schatzkin A., Carroll R.J. Structure of dietary measurement error: Results of the OPEN biomarker study. Am J Epidemiol 2003, 158:14-21.
70. Kluijtmans L.A.J., Van den Heuvel L.P.W.J, Boers G.H.J., Frosst P., Stevens E.M.B., van Oost B.A., den Heijer M., Trijbels F.J., Rozen R., Blom H.J. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996, 58:35-41.
71. Kritchevsky D. Diet and cancer: What's next?. J Nutr 2003, 133:3827S-3829S.
72. Kristal A.R., Peters U., Potter J.D. Is it time to abandon the food frequency questionnaire?. Cancer Epidemiol Biomarkers Prev 2005, 14:2826-2828.
73. Kussmann M., Raymond F., Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006, 124:758-787.
74. Lai C.Q., Tai E.S., Tan C.E., Cutter J., Chew S.K., Zhu Y.P., Adiconis X., Ordovas J.M. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003, 44:2365-2373.
75. Lai C.Q., Demissie S., Cupples L.A., Zhu Y., Adiconis X., Parnell L.D., Corella D., Ordovas J.M. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 2004, 45:2096-2105.
76. Lai C.Q., Corella D., Demissie S., Cupples L.A., Adiconis X., Zhu Y., Parnell L.D., Tucker K.L., Ordovas J.M. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: The Framingham Heart Study. Circulation 2006, 113:2062-2070.
77. Lampe J.W., Peterson S. Brassica, biotransformation and cancer risk: Genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr 2002, 132:2991-2994.
78. Le Marchand L., Wilkens L.R., Kolonel L.N., Henderson B.E. The MTHFR C677T polymorphism and colorectal cancer: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005, 14:1198-1203.
79. Leong N.M., Mignone L.I., Newcomb P.A., Titus-Ernstoff L., Baron J.A., Trentham-Dietz A., Stampfer M.J., Willett W.C., Egan K.M. Early life risk factors in cancer: The relation of birth weight to adult obesity. Int J Cancer 2003, 103:789-791.
80. Lin H.J., Probst-Hensch N.M., Louie A.D., Kau I.H., Witte J.S., Ingles S.A., Frankl H.D., Lee E.R., Haile R.W. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998, 7:647-652.
81. Little J., Bradley L., Bray M.S., Clyne M., Dorman J., Ellsworth D.L., Hanson J., Khoury M., Lau J., O'Brien T.R., et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002, 156:300-310.
82. Liu R.H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 2003, 78:517S-520S.
83. Loktionov A. Common gene polymorphisms and nutrition: Emerging links with pathogenesis of multifactorial chronic diseases. J Nutr Biochem 2003, 14:426-451.
84. Lopez-Miranda J., Ordovas J.M., Espino A., Marin C., Salas J., Lopez-Segura F., Jimenez-Pereperez J., Perez-Jimenez F. Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 1994, 343:1246-1249.
85. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., Malinow M.R., Willett W.C., Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US Physicians. Circulation 1996, 94:2410-2416.
86. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997, 57:1098-1102.
87. Mahley R.W. Apolipoprotein E:cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
88. Mandell B.F. Who is conducting the deadly quartet?. Cleve Clin J Med 2002, 69:927.
89. Manolio T.A., Bailey-Wilson J.E., Collins F.S. Genes, environment and the value of prospective cohort studies. Nat Rev Genet 2006, 7:812-820.
90. Martini M.C., Campbell D.R., Gross M.D., Grandits G.A., Potter J.D., Slavin J.L. Plasma carotenoids as biomarkers of vegetable intake: The University of Minnesota Cancer Prevention Research Unit Feeding Studies. Cancer Epidemiol Biomarkers Prev 1995, 4:491-496.
91. Masson L.F., McNeill G., Avenell A. Genetic variation and the lipid response to dietary intervention: A systematic review. Am J Clin Nutr 2003, 77:1098-1111.
92. Mata P., Lopez-Miranda J., Pocovi M., Alonso R., Lahoz C., Marin C., Garces C., Cenarro A., Perez-Jimenez F., de Oya M., et al. Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 1998, 137:367-376.
93. Mazhar D., Waxman J. Dietary fat and breast cancer. QJM 2006, 99:469-473.
94. Mensink R.P., Plat J. Post-genomic opportunities for understanding nutrition: The nutritionist's perspective. Proc Nutr Soc 2002, 61:401-404.
95. Meyer F., White E. Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol 1993, 138:225-236.
96. Millen B.E., Quatromoni P.A., Nam B.H., Pencina M.J., Polak J.F., Kimokoti R.W., Ordovas J.M., D'Agostino R.B. Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: The Framingham Nutrition Studies. Am J Clin Nutr 2005, 82:174-180.
97. Millen B.E., Pencina M.J., Kimokoti R.W., Zhu L., Meigs J.B., Ordovas J.M., D'Agostino R.B. Nutritional risk and the metabolic syndrome in women: Opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr 2006, 84:434-441.
98. Milner J.A., Allison R.G., Elliott J.G., Go V.L., Miller G.A., Rock C., Roy R., Wargovich M.J. Opportunities and challenges for future nutrition research in cancer prevention: A panel discussion. J Nutr 2003, 133:2502S-2504S.
99. Milner J.A. Incorporating basic nutrition science into health interventions for cancer prevention. J Nutr 2003, 133:3820S-3826S.
100. Most M.M., Ershow A.G., Clevidence B.A. An overview of methodologies, proficiencies, and training resources for controlled feeding studies. J Am Diet Assoc 2003, 103:729-735.
101. Mottagui-Tabar S., Ryden M., Lofgren P., Faulds G., Hoffstedt J., Brookes A.J., Andersson I., Arner P. Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis. Diabetologia 2003, 46:789-797.
102. Muller M., Kersten S. Nutrigenomics: Goals and strategies. Nat Rev Genet 2003, 4:315-322.
103. Murray J.A. The widening spectrum of celiac disease. Am J Clin Nutr 1999, 69:354-365.
104. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., Dietz W.H. The disease burden associated with overweight and obesity. JAMA 1999, 282:1523-1529.
105. Nambi V., Hoogwerf R.J., Sprecher D.L. A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. Cleve Clin J Med 2002, 69:985-989.
106. Neuhouser M.L., Patterson R.E., King I.B., Horner N.K., Lampe J.W. Selected nutritional biomarkers predict diet quality. Public Health Nutr 2003, 6:703-709.
107. Nicolae D.L., Wen X., Voight B.F., Cox N.J. Coverage and characteristics of the Affymetrix GeneChip Human Mapping 100K SNP set. PLoS Genet 2006, 2:e67.
108. Novelli G., Reichardt J.K. Molecular basis of disorders of human galactose metabolism: Past, present, and future. Mol Genet Metab 2000, 71:62-65.
109. Ordovas J.M. The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc 1999, 58:171-187.
110. Ordovas J.M. Gene-diet interaction and plasma lipid response to dietary intervention. Curr Atheroscler Rep 2001, 3:200-208.
111. Ordovas J.M. Gene-diet interaction and plasma lipid responses to dietary intervention. Biochem Soc Trans 2002, 30:68-73.
112. Ordovas J.M. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr 2006, 83:443S-446S.
113. Ordovas J.M. Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc 2006, 106:1074-1081.
114. Ordovas J.M., Mooser V. The APOE locus and the pharmacogenetics of lipid response. Curr Opin Lipidol 2002, 13:113-117.
115. Ordovas J.M., Corella D., Cupples L.A., Demissie S., Kelleher A., Coltell O., Wilson P.W., Schaefer E.J., Tucker K. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study. Am J Clin Nutr 2002, 75:38-46.
116. Ordovas J.M., Corella D., Demissie S., Cupples L.A., Couture P., Coltell O., Wilson P.W., Schaefer E.J., Tucker K.L. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: Evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 2002, 106:2315-2321.
117. Ordovas J.M., Litwack-Klein L., Wilson P.W.F., Schaefer M.M., Schaefer E.J. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987, 28:371-380.
118. Otani T., Iwasaki M., Hanaoka T., Kobayashi M., Ishihara J., Natsukawa S., Shaura K., Koizumi Y., Kasuga Y., Yoshimura K., et al. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 2005, 53:42-50.
119. Oxman A.D., Sackett D.L., Guyatt G.H. Users' guides to the medical literature. I. How to get started. The evidence-based medicine working group. JAMA 1993, 270:2093-2095.
120. Pagani F., Giudici G.A., Baralle F.E., Vergani C. Association of a polymorphism in the apoA-I gene promoter with hyperalphalipoproteinemia. Eur J Epidem 1992, 8:54-58.
121. Page G.P., Edwards J.W., Barnes S., Weindruch R., Allison D.B. A design and statistical perspective on microarray gene expression studies in nutrition: The need for playful creativity and scientific hard-mindedness. Nutrition 2003, 19:997-1000.
122. Pena A.S., Mann D.L., Hague N.E., Heck J.A., van Leeuwen A., van Rood J.J., Strober W. Genetic basis of gluten-sensitive enteropathy. Gastroenterology 1978, 75:230-235.
123. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.C., Krauss R.M., Rubin E.M. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
124. Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M., Cohen J.C. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002, 11:3031-3038.
125. Perera F.P., Weinstein I.B. Molecular epidemiology: Recent advances and future directions. Carcinogenesis 2000, 21:517-524.
126. Peters E.S., McClean M.D., Liu M., Eisen E.A., Mueller N., Kelsey K.T. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev 2005, 14:476-482.
127. Philpott C.C. Molecular aspects of iron absorption: Insights into the role of HFE in hemochromatosis. Hepatology 2002, 35:993-1001.
128. Poschl G., Stickel F., Wang X.D., Seitz H.K. Alcohol and cancer: Genetic and nutritional aspects. Proc Nutr Soc 2004, 63:65-71.
129. Potter J.D. Epidemiology, cancer genetics and microarrays: Making correct inferences, using appropriate designs. Trends Genet 2003, 19:690-695.
130. Pras E. Cystinuria at the turn of the millennium: Clinical aspects and new molecular developments. Mol Urol 2000, 4:409-414.
131. Prentice R.L., Sugar E., Wang C.Y., Neuhouser M., Patterson R. Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease. Public Health Nutr 2002, 5:977-984.
132. Prentice R.L., Caan B., Chlebowski R.T., Patterson R., Kuller L.H., Ockene J.K., Margolis K.L., Limacher M.C., Manson J.E., Parker L.M., et al. Low-fat dietary pattern and risk of invasive breast cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295:629-642.
133. Powers H.J. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr 2005, 135(Suppl 12):2960S-2966S.
134. Prietsch V., Lindner M., Zschocke J., Nyhan W.L., Hoffmann G.F. Emergency management of inherited metabolic diseases. J Inherit Metab Dis 2002, 25:531-546.
135. Purohit V., Khalsa J., Serrano J. Mechanisms of alcohol-associated cancers: Introduction and summary of the symposium. Alcohol 2005, 35:155-160.
136. Qi L., Corella D., Sorli J.V., Portoles O., Shen H., Coltell O., Godoy D., Greenberg A.S., Ordovas J.M. Genetic variation at the perilipin (PLIN) locus is associated with obesity-related phenotypes in White women. Clin Genet 2004, 66:299-310.
137. Qi L., Shen H., Larson I., Schaefer E.J., Greenberg A.S., Tregouet D.A., Corella D., Ordovas J.M. Gender-specific association of a perilipin gene haplotype with obesity risk in a white population. Obes Res 2004, 12:1758-1765.
138. Qi L., Tai E.S., Tan C.E., Shen H., Chew S.K., Greenberg A.S., Corella D., Ordovas J.M. Intragenic linkage disequilibrium structure of the human perilipin gene (PLIN) and haplotype association with increased obesity risk in a multiethnic Asian population. J Mol Med 2005, 83:448-456.
139. Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., Walts B., Perusse L., Bouchard C. The human obesity gene map: The 2005 update. Obesity 2006, 14:529-644.
140. Riboli E., Hunt K.J., Slimani N., Ferrari P., Norat T., Fahey M., Charrondiere U.R., Hemon B., Casagrande C., Vignat J., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection. Public Health Nutr 2002, 5(6B):1113-1124.
141. Ridel K.R., Leslie N.D., Gilbert D.L. An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol 2005, 33:153-161.
142. Roberts M.A., Mutch D.M., German J.B. Genomics: Food and nutrition. Curr Opin Biotechnol 2001, 12:516-522.
143. Roberts-Thomson I.C., Ryan P., Khoo K.K., Hart W.J., McMichael A.J., Butler R.N. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996, 347:1372-1374.
144. Rock C.L., Lampe J.W., Patterson R.E. Nutrition, genetics, and risks of cancer. Annu Rev Public Health 2000, 21:47-64.
145. Rubin J., Berglund L. Apolipoprotein E and diets: A case of gene-nutrient interaction?. Curr Opin Lipidol 2002, 13:25-32.
146. Salem R.M., Wessel J., Schork N.J. A comprehensive literature review of haplotyping software and methods for use with unrelated individuals. Hum Genomics 2005, 2:39-66.
147. Santos L.L., Magalhaes M de C., Januario J.N., Aguiar M.J., Carvalho M.R. The time has come: A new scene for PKU treatment. Genet Mol Res 2006, 31:33-44.
148. Schaefer E.J., Lamon-Fava S., Johnson S., Ordovas J.M., Schaefer M.M., Castelli W.P., Wilson P.W. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: Results from the Framingham Offspring Study. Arterioscler Thromb 1994, 14:1105-1113.
149. Schaefer E.J., Augustin J.L., Schaefer M.M., Rasmussen H., Ordovas J.M., Dallal G.E., Dwyer J.T. Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr 2000, 71:746-751.
150. Scriver C.R. Garrod's foresight, our hindsight. J Inherit Metab Dis 2001, 24:93-116.
151. Scriver C.R., Waters P.J. Monogenic traits are not simple: Lessons from phenylketonuria. Trends Genet 1999, 15:267-272.
152. Sebat J., Lakshmi B., Troge J., Alexander J., Young J., Lundin P., Maner S., Massa H., Walker M., Chi M., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
153. Segrest J.P., Li L., Anantharamaiah G.M., Harvey S.C., Liadaki K.N., Zannis V. Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr Opin Lipidol 2000, 11:105-115.
154. Seitz H.K., Maurer B., Stickel F. Alcohol consumption and cancer of the gastrointestinal tract. Dig Dis 2005, 23:297-303.
155. Sempos C.T., Liu K., Ernst N.D. Food and nutrient exposures: What to consider when evaluating epidemiologic evidence. Am J Clin Nutr 1999, 69:1330-1338.
156. Shamir R. Advances in celiac disease. Gastroenterol Clin North Am 2003, 32:931-947.
157. Sharp L., Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 2004, 159:423-443.
158. Slattery M.L., Potter J.D., Samowitz W., Schaffer D., Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1999, 8:513-518.
159. Slimani N., Kaaks R., Ferrari P., Casagrande C., Clavel-Chapelon F., Lotze G., Kroke A., Trichopoulos D., Trichopoulou A., Lauria C., et al. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: Rationale, design and population characteristics. Public Health Nutr 2002, 5:1125-1145.
160. Sonnenberg L., Pencina M., Kimokoti R., Quatromoni P., Nam B.H., D'Agostino R., Meigs J.B., Ordovas J., Cobain M., Millen B. Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res 2005, 13:153-162.
161. Stover P.J. Influence of human genetic variation on nutritional requirements. Am J Clin Nutr 2006, 83:436S-442S.
162. Stram D.O., Hankin J.H., Wilkens L.R., Pike M.C., Monroe K.R., Park S., Henderson B.E., Nomura A.M., Earle M.E., Nagamine F.S., et al. Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol 2000, 151:358-370.
163. Stram D.O., Leigh Pearce C., Bretsky P., Freedman M., Hirschhorn J.N., Altshuler D., Kolonel L.N., Henderson B.E., Thomas D.C. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 2003, 55:179-190.
164. Suh Y., Vijg J. SNP discovery in associating genetic variation with human disease phenotypes. Mutat Res 2005, 573:41-53.
165. Swallow D.M. Genetics of lactase persistence and lactose intolerance. Annu Rev Genet 2003, 37:197-219.
166. Tai E.S., Corella D., Deurenberg-Yap M., Cutter J., Chew S.K., Tan C.E., Ordovas J.M. Dietary fat interacts with the H11002514C H11022 T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: The 1998 Singapore National Health Survey. J Nutr 2003, 133:3399-3408.
167. Talmud P.J., Ye S., Humphries S.E. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study. Genet Epidemiol 1994, 11:265-280.
168. Tamer L., Ercan B., Ates N.A., Degirmenci U., Unlu A., Ates C., Dirlik M., Atik U. N-acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma. Cell Biochem Funct 2006, 24:131-135.
169. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. (2002). Circulation 106, 3143-3421.
170. Tinker A. The social implications of an ageing population. Mech Ageing Dev 2002, 123:729-735.
171. Tiret L. Gene-environment interaction: A central concept in multifactorial diseases. Proc Nutr Soc 2002, 61:457-463.
172. Uauy R., Solomons N. Diet, nutrition, and the life-course approach to cancer prevention. J Nutr 2005, 135(12 Suppl):2934S-2945S.
173. Ulrich C.M. Nutrigenetics in cancer research-folate metabolism and colorectal cancer. J Nutr 2005, 135:2698-2702.
174. Ulrich C.M., Kampman E., Bigler J., Schwartz S.M., Chen C., Bostick R., Fosdick L., Beresford S.A., Yasui Y., Potter J.D. Colorectal adenomas and the C677T MTHFR polymorphism: Evidence for gene-environment interaction?. Cancer Epidemiol Biomarkers Prev 1999, 8:659-668.
175. van den Donk M., Buijsse B., van den Berg S.W., Ocke M.C., Harryvan J.L., Nagengast F.M., Kok F.J., Kampman E. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: A Dutch case-control study. Cancer Epidemiol Biomarkers Prev 2005, 14:1562-1566.
176. van Ommen B., Stierum R. Nutrigenomics: Exploiting systems biology in the nutrition and health arena. Curr Opin Biotechnol 2002, 13:517-521.
177. Vineis P. Diet, genetic susceptibility and carcinogenesis. Public Health Nutr 2001, 4:485-491.
178. *1 allele, possibly due to salivary acetaldehyde. Gut 2004, 53:871-876.
179. Walter J.H., Collins J.E., Leonard J.V. Recommendations for the
180. Wang D., Ritchie J.M., Smith E.M., Zhang Z., Turek L.P., Haugen T.H. Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev 2005, 14:626-632.
181. Wang J., Gajalakshmi V., Jiang J., Kuriki K., Suzuki S., Nagaya T., Nakamura S., Akasaka S., Ishikawa H., Tokudome S. Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: A case-control study in an Indian population. Int J Cancer 2006, 118:991-997.
182. Willett W.C. Nutritional epidemiology: Issues and challenges. Int J Epidemiol 1987, 16:312-317.
183. Willett W.C. Nutritional epidemiology issues in chronic disease at the turn of the century. Epidemiol Rev 2000, 22:82-86.
184. Young V.R. 2001 W.O. Atwater Memorial Lecture and the 2001 ASNS President's Lecture: Human nutrient requirements: the challenge of the post-genome era. J Nutr 2002, 132:621-629.
185. Zambon A., Deeb S.S., Hokanson J.E., Brown B.G., Brunzell J.D. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 1998, 18:1723-1729.
186. Zhang S. A prospective study of folate intake and the risk of breast cancer. JAMA 1999, 281:1632-1637.